Reliable in use, removable when needed – Next-gen adhesive solutions that can be precisely and residue-free removedInnovation hub with impact – Accelerating customer-specific developments...
Munich, Germany – July 2, 2025 -- Ebenbuild, a company developing personalized, AI-enabled digital twins of lungs to support clinical decisions and digital clinical trials, today announced that it has received Euro 2.3 million funding under the European Innovation Council (EIC) Accelerator program to advance its digital twin platform technology. In addition, the EIC fund will invest up to €10 million in future equity financing rounds raised by Ebenbuild. The funding will support the market launch of Twinhale, the first in silico trial software built for pulmonary drug delivery. The investment also underpins Ebenbuild’s broader platform strategy to transform respiratory care through personalized lung simulation – from drug development to mechanical ventilation optimization in critical care.
PARIS, July 2, 2025 /PRNewswire/ -- OKX, a leading crypto exchange and global onchain technology company, has officially launched its fully regulated centralized crypto...
PADUA, Italy and LONDON, July 1, 2025 /PRNewswire/ -- Safilo Group – one of the eyewear industry's key players in the design, manufacturing and distribution...
LIMASSOL, Cyprus, July 1, 2025 /PRNewswire/ -- B2PRIME Group, a global financial services provider for institutional and professional clients, hosted its exclusive B2MEET event...
GOTHENBURG, Sweden, June 27, 2025 /PRNewswire/ -- Minesto, leading ocean energy developer, is heading a consortium of four that has been awarded a total...
GOTHENBURG, Sweden, June 27, 2025 /PRNewswire/ -- Minesto, leading ocean energy developer, is heading a consortium of four that has been awarded a total...
GOTHENBURG, Sweden, June 27, 2025 /PRNewswire/ -- Minesto, leading ocean energy developer, is heading a consortium of four that has been awarded a total...